Harbour BioMed takes in Series A+ funding
China and Newton, Massachusetts-based Harbour BioMed, a developer of therapeutics for cancer, has closed an undisclosed amount of Series A+ financing. The investors were CDH Investments and Advantech Capital.
22 January 2018•1 min read
